Crescent Biopharma, Inc. (CBIO) vs Eupraxia Pharmaceuticals Inc. (EPRX)

Crescent Biopharma, Inc. and Eupraxia Pharmaceuticals Inc. are both Biotechnology companies. Crescent Biopharma, Inc. and Eupraxia Pharmaceuticals Inc. are of similar size ($537.8M and $528.9M). Across the 9 metrics below, Crescent Biopharma, Inc. leads on 5 and Eupraxia Pharmaceuticals Inc. on 4.

Valuation

Metric CBIO EPRX Biotechnology median
P/E n/m n/m 7.88
P/S 350.63 n/m 11.47
P/B 2.68 5.30 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 240.54 n/m 10.73
Earnings yield (48.03%) (12.73%) (28.84%)
Free cash flow yield (16.82%) (7.21%) (23.03%)

Profitability

Metric CBIO EPRX Biotechnology median
Gross margin 19.72% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (112.14%) (117.82%) (57.72%)
Return on assets (97.08%) (64.44%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBIO EPRX Biotechnology median
Revenue growth (TTM) (45.09%) — 5.64%
EPS growth (last fiscal year) 44.97% (35.53%) —
Revenue growth, 5-year CAGR 257.77% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CBIO EPRX Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 9.66 16.00 4.73
Net debt to EBITDA 1.40 2.11 0.96

Dividend

Metric CBIO EPRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CBIO EPRX Biotechnology median
Market cap 528.93m 537.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack